NewKerala.com

Delhi Seizes ₹20 Lakh Insulin Stock in Major Drug Storage Crackdown

The Delhi Drugs Control Department has seized insulin preparations worth over ₹20 lakh from wholesale drug firms for serious regulatory violations. During a special drive, inspectors found four firms violating the Drugs and Cosmetics Act, with insulin stored at improper temperatures and labels defaced for government supply. Delhi Health Minister Pankaj Kumar Singh emphasized that violations involving life-saving medicines will face strict legal action. The department has booked two firms and sent drug samples for testing to verify quality and compliance.

Key Points: Delhi Seizes ₹20 Lakh Insulin in Drug Storage Violation Crackdown

  • 2,104 insulin units seized worth ₹20.06 lakh
  • Four of six firms violated Drugs Act
  • Insulin stored at room temperature, breaking cold chain
  • Labels defaced, meant for government supply
2 min read

Delhi Drugs Control Department seizes insulin stock worth Rs 20.06 lakh

Delhi Drugs Control seizes insulin worth ₹20.06 lakh from wholesalers for cold chain violations and defaced labels meant for government supply.

"Any violation involving life-saving medicines like insulin will invite strict action under the law. - Delhi Health Minister Pankaj Kumar Singh"

New Delhi, March 6

The Delhi Drugs Control Department conducted a special enforcement drive at a wholesale drug market in Delhi to ensure the availability of safe, effective and quality medicines to the public, particularly insulin preparations that require strict cold chain maintenance.

During the inspection, a total of six wholesale drug firms were inspected, out of which four firms were found violating provisions of the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945. A large quantity of insulin preparations, including Tresiba FlexTouch 100U/ml Pen, Glaritus 100U/ml Cartridges, Humalog Mix50 KwikPen 100U/ml, Apidra SoloStar 100U/ml and Toujeo SoloStar 300U/ml, were found stocked with defaced inscriptions on labels that are meant for Government or institutional supply.

The concerned firms failed to produce valid purchase records for the said stock. Additionally, two firms were found storing insulin preparations at normal room temperature, in violation of prescribed storage conditions that mandate strict cold chain maintenance.

In total, 2,104 units of insulin preparations worth ₹20,06,024 were seized during the enforcement drive.

Speaking on the action, Delhi Health Minister Pankaj Kumar Singh said, "Ensuring the availability of safe and effective medicines for citizens is our foremost priority. Under the leadership of Hon'ble Chief Minister Smt. Rekha Gupta, the Delhi Government, is committed to maintaining strict regulatory oversight on drug storage and distribution. Any violation involving life-saving medicines like insulin will invite strict action under the law."

Following the inspection, two firms have been booked for violations under the relevant provisions of the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945. Additionally, drug samples have been collected and sent for testing and analysis to verify their quality and compliance with prescribed standards.

The Delhi Drugs Control Department reiterated its commitment to safeguarding public health and ensuring strict compliance with statutory provisions related to the storage and distribution of life-saving medicines.

- ANI

Share this article:

Reader Comments

R
Rohit P
Good step by the Delhi government. The defaced labels meant for institutional supply is a huge red flag. This stock was probably meant to be diverted and sold at higher prices in the open market. This drives up costs for common people. More such raids are needed across India.
D
David E
As someone with a family member who depends on insulin, this news is terrifying. We trust chemists to provide safe medicine. How can we be sure what we're buying is potent if the cold chain is broken? The system needs more transparency and maybe a way for consumers to verify storage history.
A
Aman W
While the action is commendable, I hope this isn't just a one-time drive for headlines. Regulatory oversight needs to be consistent and robust. What about the other cities? The entire supply chain, from manufacturer to local pharmacy, needs regular, surprise checks.
S
Shreya B
₹20 lakhs worth of insulin seized! Imagine how many patients could have been put at risk. The lack of purchase records shows complete negligence. The government should name and shame these firms so people know where not to buy from. Public safety comes first.
K
Karthik V
This is a serious issue. But also, we need to think about why this happens. Maybe the profit margins are low or the cold storage infrastructure is too expensive for small wholesalers? Not justifying the crime, but the government should also look at supporting compliant businesses to prevent such violations.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50